Adeona Pharmaceuticals, Inc. (AEN) Announces Appointment of James S. Kuo, M.D. as Chairman, CEO and President
Adeona Pharmaceuticals, Inc., a development-stage, specialty pharmaceutical company that is developing orally active, proprietary, late-stage drug candidates for the treatment of autoimmune and central nervous system diseases, recently announced the appointment of James S. Kuo, M.D. as the company’s chairman, chief executive officer and president. Dr. Kuo replaces Mr. Max Lyon, who recently resigned as president, chief executive officer and a member of the company’s board of directors. Since February of 2007, Dr. Kuo has served as a director of Adeona Pharmaceuticals. In his new role, he will spearhead the company’s new growth initiatives, including new product launches, the commercialization…